GoliniA., LoriA.: Aging of the population, demographic and social changes. Aging, 2: 319–336, 1990.
2.
YancikR.: Epidemilogy of cancer in the elderly. Current status and projections for the future. Rays, 22: 3–9.
3.
FranceschiS., La VecchiaC.: Cancer Epidemiology in the elderly. Crit Rev Oncol Hematol, 39: 219–226, 2001.
4.
SaikaT., SuyamaB., MurataT., ManabeD., KurashigeT., NasuY.: Orthotopic neobladder reconstruction in elderly bladder cancer patients. Int J Urol, 8: 533–538, 2001.
5.
ChangS.S., AlbertsG., CooksonM.S., SmithJAJr.: Radical cystectomy is safe in elderly patients at high risk. J Urol, 166: 938–941, 2001.
6.
GameX., SoulieM., SeguinP., VazzolerN., TollonC., PontonnierF.: Radical cystectomy in patients older than 75 years: assessment of morbidity and mortality. Eur Urol, 39: 525–529, 1991.
7.
FigueroaA.J., SteinJ.P., DickinsonM., SkinnerE.C., Thangathu-raiD., MakhailM.S.: Radical cystectomy for elderly patients with bladder carcinoma: an updated experience with 404 patients. Cancer, 83: 141–147, 1998.
8.
HolmangS., HedelinH., BorghedeG., JohanssonS.L.: Long-term follow up of a bladder carcinoma cohort: questionable value of radical radiotherapy. J Urol, 157: 1642–1646, 1997.
9.
AriasF., DuenasM., MartinezE., DominguezM.A., Illarramen-diJ.J., VillafrancaE.: Radical chemoradiotherapy for elderly patients with bladder carcinoma invading muscle. Cancer, 80: 115–120, 1997.
10.
ChauvetB., BrewerY., Felix-FaureC., DavinJ.L., ChoquenetC., ReboulF.: Concurrent cisplatin and radiotherapy for patients with muscle invasive bladder cancer who are not candidates for radical cystectomy. J Urol, 156: 1258–1262, 1996.
GellerN.L., SternbergC.N., PenenbergD., ScherH., YagodaA.: Prognostic factors for survival of patients with advanced urothelial tumors treated with methotrexate, vinblastine, doxorubicin, and cisplatin chemotherapy. Cancer, 67: 1525–1531, 1991.
13.
BajorinD.F., DoddP.M., MazumdarM., FazzariM., McCaffreyJ.A., ScherH.I.: Long-term survival in metastatic transitional-cell carcinoma and prognostic factors predicting outcome of therapy. J Clin Oncol, 17: 3173–3181, 1999.
14.
BellmuntJ., RibasA., EresN., AlbanellJ., ConcepciónA., Be-goñaB.: Carboplatin-based versus cisplatin-based chemotherapy in the treatment of surgically incurable advanced bladder carcinoma. Cancer, 80: 1966–1972, 1997.
15.
SternbergC.N.: Gemcitabine in Bladder Cancer. Sem Oncol, 27: 31–39, 2000.
16.
BellmuntJ., De WitR., AlbanellJ., BaselgaJ.: A feasibility study of carboplatin with fixed dose of gemcitabine in ‘unfit’ patients with advanced bladder cancer. Eur J Cancer, 37: 2212–2215, 2001.
17.
CarlesJ., NogueM.: Gemcitabine/carboplatin in advanced urothelial cancer. Sem Oncol, 28: 19–24, 2001.
